HONG KONG – Preclinical data from a Sino-US study suggest that a tyrosine kinase inhibitor originally developed to treat lymphoma and leukemia, Imbruvica (ibrutinib, Abbvie Inc./Johnson & Johnson), could also target glioma stem cells (GSCs), effectively controlling glioblastoma growth.
A Chinese study has for the first time identified a key protein, known as LIMA1, which was shown to regulate intestinal cholesterol absorption in both mouse models and in humans.
A Chinese study has for the first time identified a key protein, known as LIMA1, which was shown to regulate intestinal cholesterol absorption in both mouse models and in humans.
HONG KONG – Preclinical data from a Sino-US study suggest that a tyrosine kinase inhibitor originally developed to treat lymphoma and leukemia, Imbruvica (ibrutinib, Abbvie Inc./Johnson & Johnson), could also target glioma stem cells (GSCs), effectively controlling glioblastoma growth.
Australian scientists have found a new way to make molecular isomers, opening up the possibility of a new area of chemistry and the development of countless new drugs and other useful new materials.
Australian scientists have found a new way to make molecular isomers, opening up the possibility of a new area of chemistry and the development of countless new drugs and other useful new materials.
HONG KONG – An international study led by the University of South Florida (USF) has revealed important new information regarding the critical genes of the deadly malarial parasite, Plasmodium falciparum, which could help investigators prioritize targets for future development of newer, more effective antimalarial drugs.
HONG KONG – An international study led by the University of South Florida (USF) has revealed important new information regarding the critical genes of the deadly malarial parasite, Plasmodium falciparum, which could help investigators prioritize targets for future development of newer, more effective antimalarial drugs.
